A British baby’s death this year after getting Novartis’s gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment’s risks.
An independent expert panel to the U.S. Food and Drug Administration on Wednesday recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their supply chains in case a chaotic Brexit disrupts the normal arteries of trade.
Sandeep Dayal is a seasoned marketing and strategy leader, with over 20 years of experience across industries and geographies. As the managing director for Cerenti, Sandeep has co-led the development of the firms' core practices in healthcare and financial services. He serves as a counselor to C-suite executives and division presidents at Fortune 500 companies and boards of directors. Over his consulting career, he has served 50+ clients on over 100 engagements around the world (including 15+ major countries in Europe, Latin America and Asia). He is regarded as one of the leading minds in Marketing and Business Strategy and has co-authored multiple articles in publications including Marketing Management, The McKinsey Quarterly and Strategy & Business.